Can Third Harmonic Bio Inc. (THRD) Add Value To Your Portfolio?


As of Wednesday close, Third Harmonic Bio Inc.’s (NASDAQ:THRD) stock was down -$0.76, moving down -3.85 percent to $19.00. The average number of shares traded per day over the past five days has been 102,900 shares. 3 times new highs have been achieved over the past 5 days, with a $0.90 gain in that time frame. In the last twenty days, the average volume was 107,910.

Since last month, THRD stock rose 3.26%. Shares of the company fell to $17.01 on 10/27/22, the lowest level in the past month. Since the beginning of this year, THRD’s stock price has dropped by -3.46%. However, the stock has declined by -22.75% since its 52-week high.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Valuation Metrics

The latest dividend of $0.12 per share was paid out, remained unchanged from last year’s $0.12.

Financial Health

In the recent quarter, Third Harmonic Bio Inc.’s quick ratio stood at 47.90, while its current ratio was 47.90, showing that the company is able to pay off its debt.

Technical Picture

This quick technical analysis looks at Third Harmonic Bio Inc.’s (THRD) price momentum. With a historical volatility rate of 64.30%, the RSI 9-day stood at 46.99% on 23 November.

With respect to its five-day moving average, the current Third Harmonic Bio Inc. price is up by +4.97% percent or $0.90. At present, THRD shares trade +6.56% above its 20-day simple moving average.

Stochastic coefficient K was 31.57% and Stochastic coefficient D was 28.26%, while ATR was 1.68. Given the Stochastic reading of 29.34% for the 14-day period, the RSI (14) reading has been calculated as 47.85%. As of today, the MACD Oscillator reading stands at 0.45, while the 14-day reading stands at -0.07.

Analyst Ratings

Morgan Stanley launched its rating on Third Harmonic Bio Inc. (NASDAQ: THRD) to an Overweight in a note to investors on October 10, 2022. Third Harmonic Bio Inc. (THRD) has been rated Buy by analysts. According to 0 brokerage firms, THRD is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Third Harmonic Bio Inc. stock as buy, with 4 recommending it as overweight.

With a median target price of $34.00, the current consensus forecast for the stock is $30.00 – $39.00. Based on these forecasts, analysts predict Third Harmonic Bio Inc. (THRD) will achieve an average price target of $34.33.


Please enter your comment!
Please enter your name here